NEOGEN CORP

NEOG · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances
213
SEC Filings

Business Summary

Neogen Corporation and its subsidiaries develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Our Food Safety segment consists primarily of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and rumi...

Next Earnings

Q2 FY2026 — expected 2026-09-20

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionNEOGdiscussed_in_filing Cybersecurity
topic_mentionNEOGdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-07-302025-05-310000950170-25-100064EDGAR52K words
2024-07-302024-05-310000950170-24-087670EDGAR—
2023-08-152023-05-310000950170-23-042861EDGAR—
2022-07-272022-05-310001193125-22-202902EDGAR—
2021-07-302021-05-310001193125-21-230829EDGAR—
2020-07-302020-05-310001193125-20-204007EDGAR—
2019-07-302019-05-310001193125-19-206929EDGAR—
2018-07-272018-05-310001193125-18-229573EDGAR—
2017-07-282017-05-310001193125-17-240208EDGAR—
2016-07-292016-05-310001193125-16-664134EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-01-082025-11-300001193125-26-007682EDGAR19K words
2025-10-092025-08-310001193125-25-235720EDGAR—
2025-04-092025-02-280000950170-25-052497EDGAR—
2025-01-152024-11-300000950170-25-005818EDGAR—
2024-10-102024-08-310000950170-24-114022EDGAR—
2024-04-092024-02-290000950170-24-042952EDGAR—
2024-01-092023-11-300000950170-24-003320EDGAR—
2023-10-102023-08-310000950170-23-052646EDGAR—
2023-04-042023-02-280000950170-23-011785EDGAR—
2023-01-092022-11-300001193125-23-004875EDGAR—
2022-09-302022-08-310001193125-22-255421EDGAR—
2022-04-012022-02-280001193125-22-093901EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-300001193125-26-130470EDGAR0K words
2026-01-080001193125-26-006990EDGAR—
2025-10-300001193125-25-257565EDGAR—
2025-10-270001193125-25-250823EDGAR—
2025-10-090001193125-25-235081EDGAR—
2025-09-150001193125-25-203554EDGAR—
2025-08-210000950170-25-110547EDGAR—
2025-08-140000950170-25-108900EDGAR—
2025-07-290000950170-25-099379EDGAR—
2025-07-240000950170-25-098159EDGAR—

213 total filings indexed. 181 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. TKNO — Alpha Teknova, Inc. AWHL — Aspira Women's Health Inc. BMRA — BIOMERICA INC BZYR — BURZYNSKI RESEARCH INSTITUTE INC CDIO — Cardio Diagnostics Holdings, Inc. CLDX — Celldex Therapeutics, Inc. IDXX — IDEXX LABORATORIES INC /DE

Company Identity

CIK0000711377
TickerNEOG
ExchangeNasdaq
SIC2835: In Vitro & In Vivo Diagnostic Substances
IncorporatedMI

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 5bf518c1fef5c4e793aacdf233b8fc21b439ee6d3832c9c3c5cae1d26cc94c77
parent: de87cefde2f86b4f8865bf3150da45c32f6eb696998d5767949846f22f1d8c74
content hash: 098d2de200431052a91f5d25141431fe3450c160c4a439e078aec994378d8faf
signed: 2026-04-13T04:46:28.526Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf